Skip to main content

Table 1 The demographic, baseline clinical characteristics of the patients

From: Effects of vitamin D supplementation on the bone specific biomarkers in HIV infected individuals under treatment with efavirenz

Characteristic Frequency, mean or median
Sex, number (percent)  
  Male 74(75.5)
  Female 24(24.5)
Age, mean(SD), years 40.26 ± 8.99
Injection drug abuse, number (percent)  
  Yes 55(56.1)
  No 43(43.9)
Duration since HIV diagnosis, median (range), month 26.5 (3–152)
Chronic hepatitis B, number (percent)  
  Yes 6(6.1)
  No 92(93.9)
Chronic hepatitis C, number (percent)  
  Yes 53(54.1)
  No 45(45.9)
GFR, mL/min/1.73 m2, number (percent)  
  ≥90 75(76.6)
  <90 23(23.4)
Calcium level mg/dl, mean (SD) 8.97 ± 0.40
Phosphorus level mg/dl, mean (SD) 3.25 ± 0.69
Parathyroid hormone level pg/ml, mean (SD) 33.92 ± 17.96
Alkaline phosphatase IU/l, mean (SD) 200.80 ± 72.05
Antiretroviral regimen, number (percent)  
  Standard (Zidovudine + lamivudine + Efavirenz) 88(89.7)
  Other 10(10.3)
  1. GFR: Glomerular filtration rate.